B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Dose CAR t strategy aims to outsmart relapsed leukemia
Disease control OngoingThis study tests whether giving a second, early infusion of the CAR T-cell therapy tisagenlecleucel can keep the immune system's B cells suppressed for at least 6 months in children and young adults with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia. About 30 part…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New cell therapy targets stubborn leukemia in kids
Disease control OngoingThis study tests a treatment called tisagenlecleucel for children and young adults (ages 1-25) with a high-risk type of B-cell leukemia. Participants have cancer cells still present after initial chemotherapy. The treatment uses the patient's own immune cells, modified to attack …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:59 UTC